US Congress House Bill 913 (Prior Session Legislation)

---

Sponsorship: Moderate Partisan Bill (Democrat 53-9)
Status: Introduced on January 30 2019 - 25% progression, died in committee
Action: 2019-01-30 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Requires state Medicaid programs to cover routine patient costs for items and services that are provided in connection with a qualifying clinical trial regarding cancer or other life-threatening conditions. The bill defines "routine patient costs" to include items and services that would otherwise be covered under Medicaid absent the patient's participation in the clinical trial; the term includes items and services relating to trial complications, but excludes those items and services that are the subject of the trial or that are provided solely in relation to data analysis. Additionally, a "qualifying clinical trial" means, among other things, a clinical trial that is approved or funded by specified entities (e.g., the National Institutes of Health) or is an authorized new drug trial.

CLINICAL TREATMENT Act Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act

Sen. Ben Lujan [D-NM]	Rep. Gus Bilirakis [R-FL]	Rep. Zoe Lofgren [D-CA]	Sen. Adam Schiff [D-CA]
Rep. Harley Rouda [D-CA]	Rep. Jamie Raskin [D-MD]	Rep. Joaquin Castro [D-TX]	Sen. Ruben Gallego [D-AZ]
Rep. Raul Grijalva [D-AZ]	Rep. Kathleen Rice [D-NY]	Rep. Vicente Gonzalez [D-TX]	Rep. Dan Crenshaw [R-TX]
Rep. Robin Kelly [D-IL]	Rep. Cindy Axne [D-IA]	Rep. Brian Fitzpatrick [R-PA]	Rep. John Katko [R-NY]
Rep. TJ Cox [D-CA]	Rep. Mark Pocan [D-WI]	Rep. Angela Craig [D-MN]	Rep. Rashida Tlaib [D-MI]
Rep. Henry Johnson [D-GA]	Rep. Betty McCollum [D-MN]	Rep. David Price [D-NC]	Rep. Paul Tonko [D-NY]
Rep. Eleanor Norton [D-DC]	Rep. Derek Kilmer [D-WA]	Rep. G. Butterfield [D-NC]	Rep. William Keating [D-MA]
Rep. Adrian Smith [R-NE]	Rep. Elaine Luria [D-VA]	Rep. Joseph Kennedy [D-MA]	Rep. Colin Allred [D-TX]
Rep. Earl Blumenauer [D-OR]	Rep. Michael Doyle [D-PA]	Rep. Tom Cole [R-OK]	Rep. Gwen Moore [D-WI]
Rep. Joyce Beatty [D-OH]	Rep. David McKinley [R-WV]	Rep. Bobby Rush [D-IL]	Rep. Grace Napolitano [D-CA]
Rep. Al Green [D-TX]	Rep. Mary Gay Scanlon [D-PA]	Rep. Madeleine Dean [D-PA]	Rep. Dwight Evans [D-PA]
Rep. Michael San Nicolas [D-GU]	Rep. Susan Davis [D-CA]	Rep. James Hagedorn [R-MN]	Rep. Max Rose [D-NY]
Rep. Debbie Dingell [D-MI]	Rep. Sharice Davids [D-KS]	Rep. Ron Kind [D-WI]	Rep. Mark DeSaulnier [D-CA]
Sen. Lisa Rochester [D-DE]	Rep. Danny Davis [D-IL]	Rep. David Trone [D-MD]	Rep. Don Young [R-AK]
Rep. Chellie Pingree [D-ME]	Rep. C.A. Ruppersberger [D-MD]	Rep. Mike Levin [D-CA]	Rep. Dean Phillips [D-MN]
Rep. Jackie Speier [D-CA]	Sen. Peter Welch [D-VT]

Date	Chamber	Action
2019-01-30	House	Referred to the House Committee on Energy and Commerce.
2019-01-30	House	Introduced in House

SB4742 (Related) 2020-09-29 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/913/all-info
Text	https://www.congress.gov/116/bills/hr913/BILLS-116hr913ih.pdf